Acoustic neuroma market seen reaching $2.81 billion by 2030

Oct. 28, 2026
Acoustic neuroma market seen reaching $2.81 billion by 2030
By AI, Created 13:15 UTC, Oct 28, 2026, AGP -

The global acoustic neuroma market is projected to grow from $1.97 billion in 2025 to $2.81 billion by 2030, driven by better imaging, wider use of proton therapy and stereotactic radiosurgery, and more healthcare investment. North America held the largest share in 2025, according to The Business Research Company.

Why it matters: - The acoustic neuroma market is expanding as diagnosis improves and treatment options broaden. - Faster imaging and more specialized care could lead to earlier detection and more targeted treatment for patients with vestibular schwannoma. - Healthcare spending is helping support the diagnostic and treatment infrastructure needed for this market.

What happened: - The Business Research Company projected the global acoustic neuroma market will rise from $1.97 billion in 2025 to $2.13 billion in 2026, then reach $2.81 billion by 2030. - The forecast implies an 8.2% compound annual growth rate in 2026 and a 7.1% CAGR through 2030. - North America held the largest share of the market in 2025. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The company also offered a free sample of the acoustic neuroma market report. - The company published a full acoustic neuroma market report.

The details: - Acoustic neuroma, also called vestibular schwannoma, is a benign tumor that starts on the vestibular nerve connecting the inner ear to the brain. - The vestibular nerve carries balance and hearing signals. - Acoustic neuromas generally grow slowly and do not metastasize. - Common symptoms include hearing loss, tinnitus, dizziness, balance difficulties, facial numbness or weakness, and coordination problems. - Historical market growth was linked to limited awareness, reliance on traditional radiation therapies, slow adoption of advanced imaging, rising hearing disorder cases and a shortage of specialized surgical centers. - Projected growth is tied to MRI and CT-scan improvements, wider use of proton therapy and stereotactic radiosurgery, higher healthcare investment, stronger patient awareness and more dedicated treatment centers. - Expected market trends include broader use of advanced imaging, more minimally invasive procedures, better proton therapy and radiosurgery techniques, personalized treatment plans and increased recognition of vestibular schwannoma symptoms. - Healthcare investment is a key growth catalyst because funding supports diagnostic tools, treatment options and patient outcomes. - The report noted that UK healthcare spending reached about £317 billion in 2024, up 6.5% from 2023, citing the UK Office for National Statistics. - The 2026 report package includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated graphics and tables.

Between the lines: - The market is moving from a niche, underdiagnosed condition toward a more structured care pathway with better imaging and more specialized treatment capacity. - The emphasis on minimally invasive procedures and personalized treatment suggests competition will increasingly center on precision and patient outcomes, not just diagnosis volume. - North America's lead in 2025 suggests the region already has stronger access to diagnostics, treatment centers and reimbursement structures than many other markets.

What's next: - Market growth will likely depend on how quickly health systems adopt advanced imaging and expand specialized treatment centers. - Continued investment in proton therapy and stereotactic radiosurgery could shape treatment preferences through 2030. - Earlier symptom recognition may push more patients into treatment sooner, supporting demand for diagnostic and surgical services. - The Business Research Company said the report is available through its sales and marketing contacts.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

United Kingdom Globe Dispatch

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

United Kingdom Globe Dispatch

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.